Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids.

Ginsel C, Plitzko B, Froriep D, Stolfa DA, Jung M, Kubitza C, Scheidig AJ, Havemeyer A, Clement B.

Drug Metab Dispos. 2018 Oct;46(10):1396-1402. doi: 10.1124/dmd.118.082453. Epub 2018 Jul 25.

PMID:
30045842
2.

The mitochondrial amidoxime reducing component (mARC): involvement in metabolic reduction of N-oxides, oximes and N-hydroxyamidinohydrazones.

Jakobs HH, Froriep D, Havemeyer A, Mendel RR, Bittner F, Clement B.

ChemMedChem. 2014 Oct;9(10):2381-7. doi: 10.1002/cmdc.201402127. Epub 2014 Jul 8.

PMID:
25045021
3.

Activation of the anti-cancer agent upamostat by the mARC enzyme system.

Froriep D, Clement B, Bittner F, Mendel RR, Reichmann D, Schmalix W, Havemeyer A.

Xenobiotica. 2013 Sep;43(9):780-4. doi: 10.3109/00498254.2013.767481. Epub 2013 Feb 4.

PMID:
23379481

Supplemental Content

Loading ...
Support Center